VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Short Bowel Syndrome

In brief

A Study of Vurolenatide in Adult Patients with Short Bowel Syndrome.

Key facts

Study ID

NCT04988997

Run by

9 Meters Biopharma, Inc.

People needed

12

Starts

2021-06-14

Expected to finish

2022-08-24

Last updated by the study team

2022-12-20

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Research Site — Gainesville, Florida, United States
• Research Site — Atlanta, Georgia, United States
• Research Site — Boston, Massachusetts, United States
• Research Site — Omaha, Nebraska, United States
• Research Site — Durham, North Carolina, United States
• Research Site — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.